AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06399926 — intervention group
Intervention type: DRUG
Intervention: Pemetrexed injection
Description: Group 1（20mg）:induction stage is 20 mg per 24 hours for 72 hours, every 2 weeks; consolidation stage is 20mg per 24 hours for 72 hours, every 3 weeks.
Study NCT06399926 — intervention group
Intervention type: DRUG
Intervention: Pemetrexed
Description: Group 2（30mg）:induction stage is 30 mg D1，every week.Consolidation stage is 30 mg D1,every 3 weeks.
Study NCT05150366 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trans thoracic echocardiography
Description: trans thoracic echocardiography at the beggining and at the end of the placement of the Saint Jude Medical AMULET type prosthesis
Study NCT06773156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab + Apatinib
Description: Adebrelimab: Administered by intravenous infusion at a fixed dose of 1200 mg. The infusion should be completed within 30-60 minutes, with a maximum duration of 2 hours. The first dose is given on Day 1, with subsequent doses repeated every 3 weeks. Dose adjustments (either up or down) are not allowed during the study. A maximum delay of 9 weeks for treatment is allowed, or treatment may be terminated.~Apatinib: 250 mg, taken orally after meals, once daily, continuously. The investigator may temporarily pause the dose or adjust the administration schedule based on symptomatic treatment, such as changing to an every-other-day (qod) schedule or a 5-day-on, 2-day-off regimen. Once toxicity resolves, treatment may resume at the original dose.~The combined treatment of Adebrelimab + Apatinib for consolidation therapy should not exceed 24 months in total.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 0 + different doses of ciprofol
Description: Sevoflurane 0% combined with ciprofol 0.1, 0.2, 0.3, 0.4, 0.6mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 0.7% + different doses of ciprofol
Description: Sevoflurane 0.7% combined with ciprofol 0.1, 0.2, 0.3, 0.4, 0.5mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0% + different doses of ciprofol 0.05
Description: Sevoflurane 1.0% combined with ciprofol 0.05, 0.1, 0.2, 0.3, 0.4mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.5% + differnet doses of ciprofol
Description: Sevoflurane 1.5% combined with ciprofol 0.05, 0.1, 0.2, 0.3, 0.4mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 2.0% + different doses of ciprofol
Description: Sevoflurane 2.0% combined with ciprofol 0.05, 0.1, 0.15, 0.2, 0.3mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane 2.5% + different doses of ciprofol
Description: Sevoflurane 2.5% combined with ciprofol 0.05, 0.1, 0.15, 0.2, 0.3mg/kg, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0 + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0 combined with sevoflurane 0.7, 1.5, 2.0, 2.5, 3.5%, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.05mg/kg + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0.05 mg/kg combined with sevoflurane 0.7, 1.5, 2.0, 2.5, 3.5 %, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.1mg/kg + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0.1mg/kg combined with sevoflurane 0.5, 1.5, 2.0, 2.5, 3.0 %, respectively.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.2 mg/kg + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0.2 mg/kg combined with sevoflurane 0.5, 1.5, 2.0, 2.5, 3.0 %, respectively.
Study NCT05596019 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: specific neurodynamic exercises
Description: Specific neurodynamic exercises in women older than 65 years with neck pain
Study NCT04931888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: EMPOWER is an adapted social emotional learning (SEL) and wellness education initiative delivered to a community of refugee families that was developed through a pre-pilot in the New Haven Afghan refugee community in 2020. Unlike traditional school-based SEL curricula, EMPOWER partners with community organizations to provide translated and trauma-informed wellness education to family units. The program combines in-person (socially distant) and remote delivery of culturally-informed physical, emotional, and medical wellness tools adapted from evidenced-based behavioral medicine, refugee trauma and recovery, and community health research.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.3 mg/kg + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0.3 mg/kg combined with sevoflurane 0.5, 1.0, 1.5, 2.0, 2.5 %, respectively.
Study NCT04931888 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: EMPOWER
Description: EMPOWER is an adapted social emotional learning (SEL) and wellness education initiative delivered to a community of refugee families that was developed through a pre-pilot in the New Haven Afghan refugee community in 2020. Unlike traditional school-based SEL curricula, EMPOWER partners with community organizations to provide translated and trauma-informed wellness education to family units. The program combines in-person (socially distant) and remote delivery of culturally-informed physical, emotional, and medical wellness tools adapted from evidenced-based behavioral medicine, refugee trauma and recovery, and community health research.
Study NCT05607212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kettlebell Swing
Description: Participants will perform two-handed kettlebell swings using the interval training protocol outlined in the study carried out by Jay et. al. (2011). The protocol calls for 30 seconds of work, followed by 30-60 seconds of rest for a total of 10 intervals. The mechanics of the kettlebell swing will follow those outlined in the study carried out by McGill et. al. (2012). All male participants will perform the intervention with a 16kg kettlebell and all female participants will perform the intervention with a 12kg kettlebell to assure reliability. The weight is higher than previous and similar study by Brandon et al to ensure measurable differences between experimental and comparison groups.
Study NCT06773351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.4 mg/kg + different end-expiratory concentration of sevoflurane
Description: Ciprofol 0.4 mg/kg combined with sevoflurane 0.5, 1.0, 1.5, 2.0, 2.5 %, respectively.
Study NCT05607212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isometric Hold
Description: Participants will perform an isometric hold of a kettlebell for 30 seconds followed by 30 seconds of rest for a total of 10 intervals. Participants will mimic initial kettlebell swing position by standing shoulder width apart with their back straight, and hips and knees flexed. Participants will be cued to squeeze their glutes and look straight ahead while they hold the weight for the 30 second interval. All male participants will perform the intervention with a 16kg kettlebell and all female participants will perform the intervention with a 12kg kettlebell to assure reliability.
Study NCT05607212 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Control group: participants will be educated on the benefit of a kettlebell swing.
Study NCT05596019 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: multimodal exercise
Description: Multimodal and nonspecific exercises in women older than 65 years with neck pain
Study NCT04498845 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In-home assessment plan
Description: The in-home family educational session provides participants with resources to identify and reduce exposures to metals in the home environment.
Study NCT04498845 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In-home assessment plan
Description: The in-home family educational session provides participants with resources to identify and reduce exposures to metals in the home environment.
Study NCT04498845 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family educational session
Description: The 1-hr in-home family educational session, administered during the first home visit to all participants, adapts a motivational interview model to reduce exposure to metals. this done by empowering families to make informed decisions regarding lead and metal exposures in their home environments that originate from different sources with an emphasis on sources from the workplace. The session will consist of both developing a plan tailored for the home and reviewing educational materials on strategies to reduce exposures in the home, focusing on barriers families experience when attempting to change their behaviors.
Study NCT04498845 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Family educational session
Description: The 1-hr in-home family educational session, administered during the first home visit to all participants, adapts a motivational interview model to reduce exposure to metals. this done by empowering families to make informed decisions regarding lead and metal exposures in their home environments that originate from different sources with an emphasis on sources from the workplace. The session will consist of both developing a plan tailored for the home and reviewing educational materials on strategies to reduce exposures in the home, focusing on barriers families experience when attempting to change their behaviors.
Study NCT04498845 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Worker take home prevention training
Description: The take home prevention 1-hour educational session guides the worker through 6 simple steps to identify and then prioritize change/s that can be made before leaving work to prevent take-home lead. It has been adapted from the AGILE model for prioritizing tasks. Participants will also be provided with a pamphlet about how to prevent lead from being taken home.
Study NCT04498845 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: D-LEAD cleaner products
Description: D-LEAD cleaner products include hand wipes, all surfaces cleaner and laundry detergent.
Study NCT06342674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Giving breast milk to the newborn according to the circadian rhythm
Description: It is the delivery of milk expressed by the newborn's mother during the neonatal intensive care unit, in accordance with the time of expression. Breast milk follows the circadian rhythm, that is, the milk the mother expresses at night will be given to her infant at night, and the milk she expresses during the day will be given to her infant during the day
Study NCT06342674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Newborns in the control group will be given expressed milk first, in line with the routine practice of the clinic
Study NCT05638048 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precision grip training
Description: First determine patients for holding the ball movement should reach the effective blood flow velocity and best duration - relaxation, and USES the electronic grips and color doppler ultrasonic diagnostic apparatus, for individual patients to choose the best grip the efforts and training, to form the best grip the training plan, and observe the scheme for Peripheral central venous catheter-associated thrombosis prevention effect.
Study NCT05638048 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use maximum strength grip training
Description: Patients were routinely implanted with PICC, and on the basis of health education in the control group, the best continuous-relaxation time, frequency and maximum grip strength of patients were used for grip strength training.
Study NCT05638048 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health education on routine grip strength training
Description: Patients were routinely implanted with PICC and received routine health education. The content of health education included face-to-face language explanation of the whole process of catheter knowledge, issuing catheter maintenance manual, issuing ordinary grip ball and telling how to use it, and follow-up.
Study NCT06549205 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: device that stimulates the dorsal surface of the tongue
Description: the device will be placed on the dorsal surface of the tongue. this instrument has two electrodes in turn connected to the TENS, so ultra low frequency stimulation (\<0.66 Hz) will be administered
Study NCT06549205 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: device that stimulates the tragus
Description: two electrodes will be placed at tragus level for the administration of dental ULFTENS
Study NCT05730179 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Conditioning stimulus
Description: Painful mechanical stimulus
Study NCT06770829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DiaFOOTCare Program
Description: The DiaFOOTCare Program includes initiatives to support diabetic foot self-management. An e-booklet on type 2 diabetes management and preventive foot care will be shared via WhatsApp or email, along with audio modules for convenient access. An interactive video featuring a simulated patient will visually demonstrate preventive foot care practices and will also be shared digitally. A 25-30-minute face-to-face training session will provide personalized education using a tablet. Goal-tracking cards will be introduced to collaboratively set three-month behavioral goals, with patients documenting their progress during the follow-up. SMS reminders will be sent three times weekly to reinforce adherence. Patients will have digital access to all DiaFOOTCare resources, including the e-booklet, audio modules, and video, for 12 weeks, ensuring accessibility via WhatsApp or email. These measures aim to enhance knowledge, behavior, and self-management practices in preventive diabetic foot care.
Study NCT06770829 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Ministry of Health and Education
Description: The active control group will receive routine outpatient follow-ups and a diabetic foot care brochure from the Ministry of Health, explained by the researcher and shared via WhatsApp or email for reference. Goal-tracking cards from the DiaFOOTCare program will be used to set individual diabetic foot self-management behavioral goals collaboratively during the initial interview. Patients will be instructed on how to complete the cards and maintain them over a three-month period. At the end of the follow-up, post-tests will assess outcomes using the Glycemic Control Form, Goal-Tracking Card, Diabetic Foot Knowledge Scale, Foot Care Behavior Scale, Nottingham Functional Foot Care Diagnostic Form, Diabetic Foot Development Follow-up Form, and Diabetic Foot Self-Management Scale. Educational resources, including the e-booklet, audio modules, and video developed in DiaFOOTCare, will also be shared via WhatsApp or email to provide additional support and enhance diabetic foot self-management.
Study NCT05929612 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra Low Dose 4 Gy Radiation
Description: 4 Gy in 2 fractions
Study NCT05684380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MAZ-101association
Description: Experimental drug
Study NCT05684380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DYMISTA®
Description: Active comparator
Study NCT05379101 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance image (CMR)
Description: A magnetic resonance imaging study for assessment of cardiac structure and intracardiac flow
Study NCT06174142 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-Frequency ESWT
Description: Participants will receive extracorporeal shock wave therapy at a frequency of 15 Hz and intensity/pressure level 3, with a total of 1800 impulses per session. This intervention will be conducted once per week for six weeks, alongside a standard physical therapy regimen
Study NCT06174142 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-Frequency ESWT Group
Description: Participants will be treated with extracorporeal shock wave therapy at a frequency of 10 Hz and intensity/pressure level 4, also with a total of 1800 impulses per session. This protocol will be delivered weekly for six sessions, accompanied by standardized physical therapy exercises.
Study NCT05379101 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic Echocardiogram (TTE)
Description: An imaging test that uses soundwaves that cannot be heard (ultrasound) to take pictures of the heart and vessels.
Study NCT06068972 — intervention group
Intervention type: DEVICE
Intervention: MolecuLight
Description: Point-of-care fluorescence imaging of high bacterial loads
Study NCT05102526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Young Millie prevention program, active teachers
Description: Prevention program: Young Mili, in collaboration with the teacher
Study NCT05102526 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevention program: Young Mili, non active teachers
Description: Prevention program: Young Mili, without the participation of the teacher
Study NCT06174142 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham ESWT Control Group
Description: Participants in this control group will undergo a sham ESWT procedure that mimics the treatment experience without actual therapeutic effects, ensuring the blinding of participants. This sham therapy will be scheduled once a week for six weeks, in conjunction with the same physical therapy program as the other groups.
Study NCT05324761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin 75mg
Description: Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Study NCT05324761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin 300mg
Description: Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Study NCT06394362 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bispectral index monitor
Description: Bispectral Index (BIS), that was introduced in 1992, is a tool that monitors the depth level of hypnosis through data processing of an electroencephalogram using computer algorithm and presented in the form of processed EEG. Utilizing BIS as a monitoring tool has shown effectiveness in reducing recovery time, prevent awareness, and bring down the amount of anesthesia agent however, as of now, it has not been incorporated into the 2020 American Society of Anesthesiologists (ASA) standard procedure on anesthesia monitoring. aims to comparing the deep hypnotic time duration on two group of geriatric patients which undergoes general anesthesia with BIS monitoring compared to standard monitoring.
Study NCT06435065 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Biodentine
Description: DIRECT PULP CAPPINGWILL BE DONE USING BIODENTINE
Study NCT06435065 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Mineral Tri-Oxide Aggregate
Description: DIRECT PULP CAPPINGWILL BE DONE USING MTA
Study NCT06435065 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: THERACAL LC
Description: DIRECT PULP CAPPINGWILL BE DONE USING THERACAL LC
Study NCT06435065 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TRISTRONTIUM ALUMINATE
Description: DIRECT PULP CAPPINGWILL BE DONE USING TRISTRONTIUM ALUMINATE
Study NCT04672161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vaccine Education
Description: A baseline educational intervention on vaccination and its role in the health maintenance of patients with IBD will be provided to all participants. Those on immunosuppressive therapies and/or those age 65 or older will also be offered the pneumonia vaccine educational intervention. Finally, patients aged 18-26 and those 27-45 who have never been vaccinated for HPV or those with high risk for HPV will additionally receive the HPV educational intervention.
Study NCT06098859 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic epidural analgesia
Description: Thoracic epidural analgesia was started preoperatively and rest posoperative 48 hours
Study NCT06098859 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spinae plane block
Description: Erector spinae plane block was applied preoperatively using local anesthetic
Study NCT06068387 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical staging
Description: para-aortic lymphadenectomy from the inferior mesenteric artery cranially to the aorta caudally via laparoscopy or laparotomy
Study NCT06228612 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: vacuum therapy
Description: vacuum therapy :all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools.
Study NCT06228612 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: maxillary stabilization splint (MSS)
Description: maxillary stabilization splint (MSS): was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth.